Frontlight ResearchEarly access
Taking people in United StatesNo phase
Registry following safety and effectiveness of vitiligo treatments in teens and adults
Follows teens and adults with vitiligo who see a skin doctor.
Key facts
- Who runs it
- CorEvitas
- Where
- Waltham, United StatesSee the site
- Trial code
- Registry title
- PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents
- Status
- Recruiting
- People taking part
- 2,500 people, planned
- Started
- 21 Aug 2026
- Expected to end
- 31 Dec 2099
- Type of study
- Observational
- Record updated
- 26 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people aged 12 and older with nonsegmental vitiligo (NSV) who are cared for by a skin doctor. It is a registry that only observes and gives no study treatment.
- Age
- 12 years and older
- Sex
- All
- Disease stage
- Nonsegmental vitiligo (NSV), confirmed by a dermatologist or a qualified skin care practitioner.
- Earlier treatment
- People can join in one of two groups. Group 1: starting a prescribed NSV medicine covered by the registry when they join. Group 2: not starting such a medicine when they join. This includes people not taking NSV medicine now, and people who took a covered NSV medicine before joining.
Main reasons for not taking part
- Taking part, or planning to take part, in a blinded clinical trial of a vitiligo treatment
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Individuals are eligible for enrollment if they meet all of the following criteria:
- Have a dermatologist- or qualified dermatology practitioner-confirmed diagnosis of nonsegmental vitiligo (NSV)
- Is at least 12 years of age or older at the time of enrollment
- Is willing and able to provide informed consent or assent, with parent/legal guardian consent as applicable
- Adult participants are willing and able to provide required personal information; Full legal name, sex, date of birth, and home ZIP/postal code
- Meet the criteria for one of the following enrollment cohorts at the time of enrollment:; Cohort 1: Eligible Medication Initiators - Individuals initiating a prescribed eligible NSV medication at the time of enrollment; Cohort 2: Not Initiating Eligible Medication - Individuals not currently receiving NSV medication at the time of enrollment, Individuals receiving eligible NSV medication prior to enrollment
Who cannot take part
- Is participating or planning to participate in a blinded clinical trial for a vitiligo therapy
- An individual who meets any of the following criteria will be excluded from participation in the registry:
Where in United States
- CorEvitas, LLCWaltham, United StatesContact: CorEvitas Vitiligo Registry TeamTaking people
About the trial
What the trial wants to find out
The design is a prospective, observational (non-interventional) registry for adolescent and adult subjects with NSV under the care of a dermatology provider.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents
- Plain-language title
- Registry following safety and effectiveness of vitiligo treatments in teens and adultsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 26 August 2026